Banka BioLoo Ltd. (BANKA) AI Stock Analysis

• Market Cap: ₹942.03M
• Dividend Yield: N/A
• Average Volume (3M): 19.62K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.43
• Revenue Growth: -3.99%
• EPS Growth: -568.31%
• Country: IN
• Employees: 1,111
• Sector: Services
• Sector Strength: N/A
• Industry: Industrial - Pollution & Treatment Controls
• EPS (TTM): <0.01
• Shares Outstanding: 10,846,582
• 10 Day Avg. Volume: 19,206
• 30 Day Avg. Volume: 19,618
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹83.00
• Price Target Upside: -4.43% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 51 Neutral
• Price Target: ₹83.00 ▼(-4.43% Downside)

Banka BioLoo Ltd.'s overall stock score is driven by critical financial performance issues, including negative profitability and cash flow challenges. Positive technical indicators provide some relief, showing potential for price stability or moderate growth. However, valuation concerns due to negative earnings and lack of dividends weigh heavily on the stock's attractiveness.

Banka BioLoo Ltd. Business Overview & Revenue Model

Company Description

Banka BioLoo Ltd. (BANKA) is an Indian company primarily engaged in providing sanitation infrastructure and human waste management solutions. The company focuses on offering innovative and sustainable sanitation solutions, particularly in areas lacking adequate sanitation facilities. Its core products and services include bio-toilets, bio-digester technology, and related sanitation services, which are designed to treat human waste in an eco-friendly manner, improving hygiene and sanitation in both urban and rural settings.

How the Company Makes Money

Banka BioLoo Ltd. generates revenue through the sale and installation of its bio-toilets and bio-digester systems. The company caters to both private and public sector clients, including Indian Railways, government bodies, and private organizations that require sustainable sanitation solutions. Additionally, Banka BioLoo may earn revenue from maintenance contracts and after-sales services associated with its bio-toilets and related infrastructure. The company’s strategic partnerships with government agencies and its involvement in public sanitation projects contribute significantly to its earnings by ensuring a steady demand for its products and services.

Banka BioLoo Ltd. Financial Statement Overview

Summary

Banka BioLoo Ltd. demonstrates significant financial difficulties, with declining revenues, profitability, and negative cash flows. The moderate debt-to-equity ratio cannot offset the risks linked to decreasing equity and increasing liabilities.

Income Statement

Banka BioLoo Ltd. has experienced a decline in revenue and profitability over the years. The gross profit margin has decreased significantly from a strong position, and the company is currently reporting negative EBIT and net income, indicating challenges in profitability and operational efficiency. The revenue growth rate has been negative in the most recent year, highlighting a contraction in sales.

Balance Sheet

The balance sheet shows a moderate debt-to-equity ratio, indicating a balanced approach to leveraging. However, the stockholders' equity has been decreasing, reflecting potential financial strain. The equity ratio remains stable but does not offset the risks associated with declining equity and increasing liabilities.

Cash Flow

Cash flow analysis reveals a negative free cash flow, indicating the company's inability to generate sufficient cash to cover its capital expenditures. The operating cash flow has also turned negative recently, which is concerning for sustaining operations without external financing. The free cash flow to net income ratio is unfavorable, pointing towards cash flow difficulties.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	556.51M	541.74M	499.96M	423.50M	387.51M	304.58M
Gross Profit	214.60M	9.87M	337.57M	368.11M	320.30M	266.47M
EBITDA	-16.20M	-28.60M	41.85M	68.94M	58.91M	40.24M
Net Income	-75.28M	-89.09M	-6.53M	25.39M	31.08M	22.05M
Balance Sheet
Total Assets	0.00	821.55M	774.23M	652.07M	640.54M	463.71M
Cash, Cash Equivalents and Short-Term Investments	51.93M	46.49M	43.85M	13.41M	8.29M	43.35M
Total Debt	0.00	347.28M	259.13M	167.15M	184.96M	116.99M
Total Liabilities	-341.27M	505.70M	376.61M	251.09M	265.52M	163.43M
Stockholders Equity	341.27M	315.13M	397.20M	400.99M	375.02M	300.28M
Cash Flow
Free Cash Flow	0.00	-69.53M	-72.06M	9.40M	-36.00M	53.55M
Operating Cash Flow	0.00	-24.71M	27.63M	73.53M	-4.40M	58.64M
Investing Cash Flow	0.00	-63.44M	-94.34M	-57.18M	-27.17M	-283.29K
Financing Cash Flow	0.00	87.50M	67.76M	-33.29M	9.55M	-36.86M

Banka BioLoo Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 86.85
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BANKA, the sentiment is Positive. The current price of 86.85 is above the 20-day moving average (MA) of 85.54, above the 50-day MA of 76.93, and above the 200-day MA of 84.74, indicating a bullish trend. The MACD of 3.50 indicates Positive momentum. The RSI at 55.55 is Neutral, neither overbought nor oversold. The STOCH value of 62.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:BANKA.

Banka BioLoo Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SPECIALITY	65 Neutral	₹5.96B	30.43		0.80%	5.42%	-35.75%
Sector *	57 Neutral	$1.60B	-3.70	3.73%	4.29%	5.38%	-37.86%
MAHEPC	55 Neutral	₹4.22B	37.81		―	13.71%	―
BANKA	51 Neutral	₹942.03M	―		―	-3.99%	-568.31%
IL&FSENGG	―	₹5.51B	―		―	―	―

Banka BioLoo Ltd. Corporate Events

Banka BioLoo Releases Financial Results for June 2025 Quarter

Banka BioLoo Limited announced the publication of its unaudited financial results for the quarter ending June 30, 2025, in prominent newspapers, complying with regulatory requirements. This timely disclosure underscores the company’s commitment to transparency and may influence stakeholder confidence as it highlights the company’s operational performance and financial health.

Banka BioLoo to Hold 13th AGM Virtually

Banka BioLoo Limited has announced that its 13th Annual General Meeting will be conducted via video conferencing on September 10, 2025. This move aligns with regulatory requirements and ensures shareholder engagement while adhering to safety protocols. The decision to hold the AGM virtually reflects the company’s adaptability and commitment to maintaining transparent communication with its stakeholders.